• Thu, May 5, 2022
Patrick Donnelly Maintained (TXG) at Strong Buy with Decreased Target to $100 on, May 5th, 2022
Patrick Donnelly of Citigroup, Maintained "10x Genomics, Inc." (TXG) at Strong Buy with Decreased Target from $150 to $100 on, May 5th, 2022.
Patrick has made no other calls on TXG in the last 4 months.
There is 1 other peer that has a rating on TXG. Out of the 1 peers that are also analyzing TXG, all agrees with Patrick's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Amit Hazan of "Goldman Sachs" Maintained at Hold with Decreased Target to $85 on, Wednesday, April 13th, 2022
Like: 👍
